GMF-beta

Product Inquiry

GMF-beta Background

Glia Maturation Factor-Beta (GMF-Beta) is a 17 kDa protein nerve gorwth factor identified as a growth and differentiation factor in the vertebrate brain._x000D_ Glia Maturation Factor-Beta stimulates differentiation of normal neurons as well as glial cells. GMFB inhibits the proliferation of the N-18 neuroblastoma line and the C6 glioma line while promoting their phenotypic expression._x000D_ GMF-beta inhances the phenotypic expression of glia & neurons thus inhibits the proliferation of their respective tumors when added to cell culture. Although astrocytes produce GMF-b and stores it inside the cells, they don’t secrete the GMF-B into the cultured medium. Cell- surface GMFb acts on the target cells at close range when cells are in direct contact. GMF-Beta is produced by thymic epithelial cells and plays an important role in T cell development in favor of CD4+ T cells._x000D_ GMF-Beta is a brain-specific protein which belongs to the actin-binding proteins (ADF) family. GMF-beta appears to play a role in the differentiation, maintenance, and regeneration of the nervous system. It also supports the progression of certain auto-immune diseases, possibly through its ability to induce the production and secretion of various pro-inflammatory cytokines.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BBT-877BBT-877Phase 2 ClinicalLegochemIdiopathic Pulmonary Fibrosis
Details
CambritaxestatIOA-289Phase 2 ClinicalMerck & Co, Cancer Research TechnologySolid tumours; Pancreatic Neoplasms
Details
ZiritaxestatGLPG-1690Phase 2 ClinicalGalapagos NvIdiopathic Pulmonary Fibrosis; Scleroderma, Systemic
Details
HNC664HNC664; HNC-664Phase 1 ClinicalGuangzhou Henovcom Bioscience Co LtdPancreatic Neoplasms; Idiopathic Pulmonary Fibrosis
Details
CudetaxestatPAT-409; BLD-0409Phase 1 ClinicalBlade Therapeutics IncMetabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Liver Diseases
Details
HNC-1058HNC-1058Phase 1 ClinicalGuangzhou Henovcom Bioscience Co LtdIdiopathic Pulmonary Fibrosis
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland